Tetra Bio-Pharma

company

About

Tetra Bio-Pharma is a biopharmaceutical company that focuses on cannabinoid-based drug development for inflammation, pain, and more.

  • 251 - 500

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$4.50M
Industries
Biopharma,Cannabis,Health Care,Medical,Pharmaceutical
Founded date
May 17, 2007
Number Of Employee
251 - 500
Operating Status
Active

Tetra Bio-Pharma is a biopharmaceutical company that focuses on cannabinoid-based drug discovery and development with a clinical program.

Tetra Bio-Pharma specializes in combining the traditional methods of medicinal cannabis use with the supporting scientific validation and safety data required for inclusion into the existing bio-pharma industry by regulators, physicians, and insurance companies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$4.50M
Tetra Bio-Pharma has raised a total of $4.50M in funding over 2 rounds. Their latest funding was raised on Feb 16, 2022 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 16, 2022 Post-IPO Debt $4.50M 1 Ministère de l'Économie et de l'Innovation Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Tetra Bio-Pharma is funded by 1 investors. Ministère de l'Économie et de l'Innovation are the most recent investors.
Investor Name Lead Investor Funding Round
Ministère de l'Économie et de l'Innovation Yes Post-IPO Debt